<DOC>
	<DOCNO>NCT01366378</DOCNO>
	<brief_summary>This open-label study assess single-dose pharmacokinetics intravenously-administered MNTX healthy adult male female subject absence , presence , orally-administered cimetidine .</brief_summary>
	<brief_title>Effect Cimetidine Single-Dose PK IV- Administered MNTX</brief_title>
	<detailed_description />
	<mesh_term>Cimetidine</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . Healthy male female age 18 45 2 . Subjects nonsmokers 3 . Subjects body weight range 154220 lb . 1 . Females pregnant lactate 2 . Subjects history clinically significant disease condition affect major organ system 3 . Subjects ECG abnormalities 4 . Subjects test positive hepatitis B , hepatitis C HIV 5 . Subjects diagnosis alcohol substance dependence past 12 month 6 . Subjects positive urine result drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>